100 related articles for article (PubMed ID: 6119637)
1. Pharmacological properties of new antipsychotic agents: use of animal models.
Puech AJ; Rioux P; Poncelet M; Brochet D; Chermat R; Simon P
Neuropharmacology; 1981 Dec; 20(12B):1279-84. PubMed ID: 6119637
[No Abstract] [Full Text] [Related]
2. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
[No Abstract] [Full Text] [Related]
3. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
Nohria V
Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
[No Abstract] [Full Text] [Related]
4. Classification of neuroleptics--zotepine.
Puech AJ; Martin P
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):1-3. PubMed ID: 2883676
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of picobenzide (3,5-dimethyl-N-(pyridin-4-ylmethyl)benzamide) analogues as potential antipsychotic agents.
Gradillas A; López B; Braña MF; Sancho I; Pérez-García C; Alguacil LF
Arzneimittelforschung; 2005; 55(12):725-9. PubMed ID: 16430025
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the pharmacological activity of N-(4-picolyl)-3,5-dimethylbenzamide (M-14012-4) and its N-oxide metabolite (M-3312-4). New pharmacological aspects].
Casais L; Colom A; Martín del Río MP; Vallejo M; Cuenca E
Arch Farmacol Toxicol; 1979 Dec; 5(3):159-64. PubMed ID: 44673
[No Abstract] [Full Text] [Related]
7. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives.
Korzycka L; Szadowska A; Pakulska W
Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
Melzacka M
Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of clomacran, a new potent psychotropic agent.
Fowler PJ; Zirkle CL; Macko E; Kaiser C; Sarau H; Tedeschi DH
Arzneimittelforschung; 1977; 27(4):866-72. PubMed ID: 17419
[No Abstract] [Full Text] [Related]
10. Differential actions of typical and atypical neuroleptic agents on two behavioural effects of apomorphine in the mouse [proceedings].
Costall B; Naylor RJ; Nohria V
Br J Pharmacol; 1978 Jun; 63(2):381P-382P. PubMed ID: 27276
[No Abstract] [Full Text] [Related]
11. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
[TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.
Hrib NJ; Jurcak JG; Bregna DE; Burgher KL; Hartman HB; Kafka S; Kerman LL; Kongsamut S; Roehr JE; Szewczak MR; Woods-Kettelberger AT; Corbett R
J Med Chem; 1996 Sep; 39(20):4044-57. PubMed ID: 8831770
[TBL] [Abstract][Full Text] [Related]
14. Behavioral pharmacologic studies in the monkey with DD-3480.
Shibuya T; Nishimori T; Matsuda H; Chen PC
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):251-4. PubMed ID: 6125481
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system activity of the proanthocyanidin-rich fraction obtained from Croton celtidifolius in rats.
Moreira EL; Rial D; Duarte FS; de Carvalho CR; Horst H; Pizzolatti MG; Prediger RD; Ribeiro-do-Valle RM
J Pharm Pharmacol; 2010 Aug; 62(8):1061-8. PubMed ID: 20663041
[TBL] [Abstract][Full Text] [Related]
16. Behavioural data suggesting the plurality of central dopamine receptors.
Costentin J; Dubuc I; Protais P
Adv Biochem Psychopharmacol; 1983; 37():289-97. PubMed ID: 6138951
[No Abstract] [Full Text] [Related]
17. Neuroleptic versus antidepressant activity of sulpiride isomers in the rat.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Adv Biochem Psychopharmacol; 1982; 31():341-6. PubMed ID: 6123224
[No Abstract] [Full Text] [Related]
18. Induction of two distinct behavioural responses by chronic treatment with ampomorphine.
Kenny M; Lynch M; Leonard BE
J Neurosci Res; 1980; 5(1):35-42. PubMed ID: 7189789
[No Abstract] [Full Text] [Related]
19. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
Surmann A; Havemann-Reinecke U
J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic/dopamine receptors: elevation and reversal.
List S; Seeman P
Adv Biochem Psychopharmacol; 1980; 24():95-101. PubMed ID: 6105811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
